Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

US Patent 11440964 · Granted Sep 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Antibodies directed against CD1272025
Antibodies directed against CD1272025
Antibodies directed against CD1272025
Uses of anti-SIRPg antibodies2025
Uses of anti-SIRPg antibodies2025
Uses of anti-SIRPg antibodies2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Method effector cells using anti-CD127 antibodies for applications in cell thera2025
Method effector cells using anti-CD127 antibodies for applications in cell thera2025